358 GLP-1R is present in bone marrow stem cells (BMSCs), 15,359 osteoblasts, 15 osteocytes, 360 and osteoclasts, 361 and GLP-1RAs have the potential to impact these cells
Research continues to explore the broader therapeutic potential of GLP-1, including its effects on the cardiovascular system, brain function, and its potential role in the treatment of conditions beyond type 2 diabetes, such as Parkinson's disease and Alzheimer's disease
They tell you to use the code if the patient is using an injectable non-insulin antidiabetic drug such as Trulicity or Victoza and any other injectable GLP-1 receptor agonist, in addition to insulin, coded with Z79.4 ( Long term (current) use of insulin ), or oral diabetes drugs, such as metformin, coded to Z79.84 ( Long term (current) use of oral hypoglycemic drugs )
The recent data provide evidence that GLP-1R activation affects the mechanisms of signal transduction associated with insulin resistance, energy homeostasis of the brain, neurogenesis, synaptic functioning, neuroinflammation and other cell responses to stress, pathological protein aggregates, proteostasis, the cerebrovascular system, and the BBB [42]
